File Download
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1371/journal.pone.0016702
- Scopus: eid_2-s2.0-79951570106
- PMID: 21347439
- WOS: WOS:000287077600020
- Find via
Supplementary
-
Bookmarks:
- CiteULike: 1
- Citations:
- Appears in Collections:
Article: Transcriptional repressive H3K9 and H3K27 methylations contribute to DNMT1-mediated DNA methylation recovery
Title | Transcriptional repressive H3K9 and H3K27 methylations contribute to DNMT1-mediated DNA methylation recovery | ||||||
---|---|---|---|---|---|---|---|
Authors | |||||||
Keywords | Cytokeratin 19 Histone h3 Demethylation DNA methylation Epigenetics | ||||||
Issue Date | 2011 | ||||||
Publisher | Public Library of Science. The Journal's web site is located at http://www.plosone.org/home.action | ||||||
Citation | Plos One, 2011, v. 6 n. 2 How to Cite? | ||||||
Abstract | DNA methylation and histone modifications are two major epigenetic events regulating gene expression and chromatin structure, and their alterations are linked to human carcinogenesis. DNA methylation plays an important role in tumor suppressor gene inactivation, and can be revised by DNA methylation inhibitors. The reversible nature of DNA methylation forms the basis of epigenetic cancer therapy. However, it has been reported that DNA re-methylation and gene re-silencing could occur after removal of demethylation treatment and this may significantly hamper the therapeutic value of DNA methylation inhibitors. In this study we have provided detailed evidence demonstrating that mammalian cells possess a bona fide DNA methylation recovery system. We have also shown that DNA methylation recovery was mediated by the major human DNA methyltransferase, DNMT1. In addition, we found that H3K9-tri-methylation and H3K27-tri-methylation were closely associated with this DNA methylation recovery. These persistent transcriptional repressive histone modifications may have a crucial role in regulating DNMT1-mediated DNA methylation recovery. Our findings may have important implications towards a better understanding of epigenetic regulation and future development of epigenetic therapeutic intervention. © 2011 Wong et al. | ||||||
Persistent Identifier | http://hdl.handle.net/10722/137626 | ||||||
ISSN | 2023 Impact Factor: 2.9 2023 SCImago Journal Rankings: 0.839 | ||||||
PubMed Central ID | |||||||
ISI Accession Number ID |
Funding Information: The study was supported by Hong Kong Research Grants Council Collaborative Research Fund (HKU 1/06C and HKU 7/CRG/09) and Michael and Betty Kadoorie Cancer Genetics Research Program 2004. I.O.L. Ng is Loke Yew Professor in Pathology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. | ||||||
References | |||||||
Grants |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Wong, CM | en_HK |
dc.contributor.author | Wong, CCL | en_HK |
dc.contributor.author | Ng, YL | en_HK |
dc.contributor.author | Au, SLK | en_HK |
dc.contributor.author | Ko, FCF | en_HK |
dc.contributor.author | Ng, IOL | en_HK |
dc.date.accessioned | 2011-08-26T14:29:38Z | - |
dc.date.available | 2011-08-26T14:29:38Z | - |
dc.date.issued | 2011 | en_HK |
dc.identifier.citation | Plos One, 2011, v. 6 n. 2 | en_HK |
dc.identifier.issn | 1932-6203 | en_HK |
dc.identifier.uri | http://hdl.handle.net/10722/137626 | - |
dc.description.abstract | DNA methylation and histone modifications are two major epigenetic events regulating gene expression and chromatin structure, and their alterations are linked to human carcinogenesis. DNA methylation plays an important role in tumor suppressor gene inactivation, and can be revised by DNA methylation inhibitors. The reversible nature of DNA methylation forms the basis of epigenetic cancer therapy. However, it has been reported that DNA re-methylation and gene re-silencing could occur after removal of demethylation treatment and this may significantly hamper the therapeutic value of DNA methylation inhibitors. In this study we have provided detailed evidence demonstrating that mammalian cells possess a bona fide DNA methylation recovery system. We have also shown that DNA methylation recovery was mediated by the major human DNA methyltransferase, DNMT1. In addition, we found that H3K9-tri-methylation and H3K27-tri-methylation were closely associated with this DNA methylation recovery. These persistent transcriptional repressive histone modifications may have a crucial role in regulating DNMT1-mediated DNA methylation recovery. Our findings may have important implications towards a better understanding of epigenetic regulation and future development of epigenetic therapeutic intervention. © 2011 Wong et al. | en_HK |
dc.language | eng | en_US |
dc.publisher | Public Library of Science. The Journal's web site is located at http://www.plosone.org/home.action | en_HK |
dc.relation.ispartof | PLoS ONE | en_HK |
dc.rights | This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. | - |
dc.subject | Cytokeratin 19 | - |
dc.subject | Histone h3 | - |
dc.subject | Demethylation | - |
dc.subject | DNA methylation | - |
dc.subject | Epigenetics | - |
dc.title | Transcriptional repressive H3K9 and H3K27 methylations contribute to DNMT1-mediated DNA methylation recovery | en_HK |
dc.type | Article | en_HK |
dc.identifier.openurl | http://library.hku.hk:4550/resserv?sid=HKU:IR&issn=1932-6203&volume=6&issue=2, abstract no. e6702&spage=1&epage=11&date=2011&atitle=Transcriptional+repressive+H3K9+and+H3K27+methylations+contribute+to+DNMT1-mediated+DNA+methylation+recovery | en_US |
dc.identifier.email | Wong, CM:jackwong@pathology.hku.hk | en_HK |
dc.identifier.email | Wong, CCL:carmencl@pathology.hku.hk | en_HK |
dc.identifier.email | Ng, IOL:iolng@hkucc.hku.hk | en_HK |
dc.identifier.authority | Wong, CM=rp00231 | en_HK |
dc.identifier.authority | Wong, CCL=rp01602 | en_HK |
dc.identifier.authority | Ng, IOL=rp00335 | en_HK |
dc.description.nature | published_or_final_version | - |
dc.identifier.doi | 10.1371/journal.pone.0016702 | en_HK |
dc.identifier.pmid | 21347439 | - |
dc.identifier.pmcid | PMC3035659 | - |
dc.identifier.scopus | eid_2-s2.0-79951570106 | en_HK |
dc.identifier.hkuros | 190837 | en_US |
dc.relation.references | http://www.scopus.com/mlt/select.url?eid=2-s2.0-79951570106&selection=ref&src=s&origin=recordpage | en_HK |
dc.identifier.volume | 6 | en_HK |
dc.identifier.issue | 2 | en_HK |
dc.identifier.spage | 1 | en_US |
dc.identifier.epage | 11 | en_US |
dc.identifier.eissn | 1932-6203 | - |
dc.identifier.isi | WOS:000287077600020 | - |
dc.publisher.place | United States | en_HK |
dc.relation.project | Molecular pathology of liver cancer - a multidisciplinary study | - |
dc.identifier.scopusauthorid | Wong, CM=16314668400 | en_HK |
dc.identifier.scopusauthorid | Wong, CCL=24823630000 | en_HK |
dc.identifier.scopusauthorid | Ng, YL=16313440600 | en_HK |
dc.identifier.scopusauthorid | Au, SLK=36460622800 | en_HK |
dc.identifier.scopusauthorid | Ko, FCF=14630572500 | en_HK |
dc.identifier.scopusauthorid | Ng, IOL=7102753722 | en_HK |
dc.identifier.citeulike | 9697731 | - |
dc.identifier.issnl | 1932-6203 | - |